INDP
Indaptus TherapeuticsDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
13
U.S. public peers
Grade Position
Below peers
vs peer average
INDP vs peer average
43/100
INDP vs. peer average (D vs. D)
Grade spread
A 1 · B 2 · C 2 · D 2 · F 4
Graded peers loaded
Coverage
13 graded
100% of tracked
Peer overview
RCEL is the first available peer comparator.
Loose same-sector, similar-cap biotechnology comp. Useful only as a small-cap biotech liquidity and event-risk read-through, not as a direct therapeutic peer.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
INDP
Indaptus Therapeutics
RCEL
AVITA Medical
Grade
D
F
Momentum
88
18
Value
42
41
Sentiment
0
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs RCEL
INDP / RCEL
Grade Position
Below peers
INDP vs. peer average (D vs. D)
43/100
Momentum
88
INDPValue
42
INDPSentiment
0
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs INDP
RCEL is the first peer returned for this comparison set.